CN110446704B - 用于制备磺酰胺结构化的激酶抑制剂的方法 - Google Patents
用于制备磺酰胺结构化的激酶抑制剂的方法 Download PDFInfo
- Publication number
- CN110446704B CN110446704B CN201880018317.4A CN201880018317A CN110446704B CN 110446704 B CN110446704 B CN 110446704B CN 201880018317 A CN201880018317 A CN 201880018317A CN 110446704 B CN110446704 B CN 110446704B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- process according
- acid
- catalyst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title abstract description 20
- 229940043355 kinase inhibitor Drugs 0.000 title abstract description 4
- 239000003757 phosphotransferase inhibitor Substances 0.000 title abstract description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 114
- 150000003839 salts Chemical class 0.000 claims abstract description 25
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 31
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 31
- 239000003054 catalyst Substances 0.000 claims description 29
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 19
- PFWWSGFPICCWGU-UHFFFAOYSA-N cyclopropanesulfonyl chloride Chemical compound ClS(=O)(=O)C1CC1 PFWWSGFPICCWGU-UHFFFAOYSA-N 0.000 claims description 16
- 235000019253 formic acid Nutrition 0.000 claims description 16
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 15
- UCNGGGYMLHAMJG-UHFFFAOYSA-N 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole Chemical compound C1=NN(C)C=C1B1OC(C)(C)C(C)(C)O1 UCNGGGYMLHAMJG-UHFFFAOYSA-N 0.000 claims description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- 229910052763 palladium Inorganic materials 0.000 claims description 11
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 10
- 150000007530 organic bases Chemical class 0.000 claims description 9
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 150000007524 organic acids Chemical class 0.000 claims description 7
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 claims description 7
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical group [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- VQCWSOYHHXXWSP-UHFFFAOYSA-N 4-bromo-2-fluoro-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Br)C=C1F VQCWSOYHHXXWSP-UHFFFAOYSA-N 0.000 claims description 5
- VLDIOICWDGMAJP-UHFFFAOYSA-N 5-(2,4-difluorophenyl)benzene-1,3-diamine Chemical compound FC1=CC=C(C2=CC(N)=CC(N)=C2)C(F)=C1 VLDIOICWDGMAJP-UHFFFAOYSA-N 0.000 claims description 5
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 150000001282 organosilanes Chemical class 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 3
- RSIHJDGMBDPTIM-UHFFFAOYSA-N ethoxy(trimethyl)silane Chemical compound CCO[Si](C)(C)C RSIHJDGMBDPTIM-UHFFFAOYSA-N 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 claims description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 claims description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 4
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 claims 3
- ZJFCBQXPTQSTCZ-UHFFFAOYSA-N n-[3-(2,4-difluorophenyl)-5-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]cyclopropanesulfonamide Chemical compound C1=NN(C)C=C1C1=CC=C(N(C=N2)C=3C=C(C=C(NS(=O)(=O)C4CC4)C=3)C=3C(=CC(F)=CC=3)F)C2=C1 ZJFCBQXPTQSTCZ-UHFFFAOYSA-N 0.000 abstract description 4
- 229940124530 sulfonamide Drugs 0.000 abstract description 3
- 108091008794 FGF receptors Proteins 0.000 abstract description 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 229940124639 Selective inhibitor Drugs 0.000 abstract description 2
- 108091008605 VEGF receptors Proteins 0.000 abstract description 2
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 abstract description 2
- 201000011510 cancer Diseases 0.000 abstract description 2
- 102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 abstract description 2
- 150000003456 sulfonamides Chemical class 0.000 abstract description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- 239000000203 mixture Substances 0.000 description 30
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 25
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- 239000000463 material Substances 0.000 description 22
- 239000000047 product Substances 0.000 description 22
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 20
- 238000001914 filtration Methods 0.000 description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 15
- -1 1-methyl-1H-pyrazol-4-yl ring Chemical group 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- WMSPXQIQBQAWLL-UHFFFAOYSA-N cyclopropanesulfonamide Chemical compound NS(=O)(=O)C1CC1 WMSPXQIQBQAWLL-UHFFFAOYSA-N 0.000 description 11
- 235000010290 biphenyl Nutrition 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- OLDMYNWXIGPOCI-UHFFFAOYSA-N 1-bromo-3,5-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC(Br)=CC([N+]([O-])=O)=C1 OLDMYNWXIGPOCI-UHFFFAOYSA-N 0.000 description 6
- CYTROQTYTIQTQK-UHFFFAOYSA-N 5-(2,4-difluorophenyl)-3-N-[4-(1-methylpyrazol-4-yl)-2-nitrophenyl]benzene-1,3-diamine Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC(=C1)N)NC1=C(C=C(C=C1)C=1C=NN(C=1)C)[N+](=O)[O-] CYTROQTYTIQTQK-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- BQLBGVYCDBBWPP-UHFFFAOYSA-N 3-N-(4-bromo-2-nitrophenyl)-5-(2,4-difluorophenyl)benzene-1,3-diamine Chemical compound BrC1=CC(=C(C=C1)NC=1C=C(C=C(C=1)N)C1=C(C=C(C=C1)F)F)[N+](=O)[O-] BQLBGVYCDBBWPP-UHFFFAOYSA-N 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 239000012453 solvate Substances 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- NMSKVMZQOZYMNA-UHFFFAOYSA-N 1-(3,5-dinitrophenyl)-2,4-difluorobenzene Chemical group FC1=C(C=CC(=C1)F)C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-] NMSKVMZQOZYMNA-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000002178 crystalline material Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QQLRSCZSKQTFGY-UHFFFAOYSA-N (2,4-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C=C1F QQLRSCZSKQTFGY-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- YIIIBLKLGXCLTP-UHFFFAOYSA-N N-[3-(2,4-difluorophenyl)-5-[4-(1-methylpyrazol-4-yl)-2-nitroanilino]phenyl]cyclopropanesulfonamide Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC(=C1)NC1=C(C=C(C=C1)C=1C=NN(C=1)C)[N+](=O)[O-])NS(=O)(=O)C1CC1 YIIIBLKLGXCLTP-UHFFFAOYSA-N 0.000 description 2
- DXRFFDWUBXLCHV-UHFFFAOYSA-N N-[3-(4-bromo-2-nitroanilino)-5-(2,4-difluorophenyl)phenyl]cyclopropanesulfonamide Chemical compound BrC1=CC(=C(C=C1)NC=1C=C(C=C(C=1)C1=C(C=C(C=C1)F)F)NS(=O)(=O)C1CC1)[N+](=O)[O-] DXRFFDWUBXLCHV-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- WDCYWAQPCXBPJA-UHFFFAOYSA-N 1,3-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC([N+]([O-])=O)=C1 WDCYWAQPCXBPJA-UHFFFAOYSA-N 0.000 description 1
- QDFKKJYEIFBEFC-UHFFFAOYSA-N 1-bromo-3-fluorobenzene Chemical compound FC1=CC=CC(Br)=C1 QDFKKJYEIFBEFC-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 1
- UQEANKGXXSENNF-UHFFFAOYSA-N 4-bromo-1-fluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Br)=CC=C1F UQEANKGXXSENNF-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- UQFQONCQIQEYPJ-UHFFFAOYSA-N N-methylpyrazole Chemical group CN1C=CC=N1 UQFQONCQIQEYPJ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- VRLDVERQJMEPIF-UHFFFAOYSA-N dbdmh Chemical compound CC1(C)N(Br)C(=O)N(Br)C1=O VRLDVERQJMEPIF-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/52—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (26)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210807243.0A CN115124470A (zh) | 2017-03-23 | 2018-03-22 | 用于制备磺酰胺结构化的激酶抑制剂的方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20175272 | 2017-03-23 | ||
FI20175272 | 2017-03-23 | ||
PCT/FI2018/050214 WO2018172616A1 (en) | 2017-03-23 | 2018-03-22 | Process for the preparation of a sulfonamide structured kinase inhibitor |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210807243.0A Division CN115124470A (zh) | 2017-03-23 | 2018-03-22 | 用于制备磺酰胺结构化的激酶抑制剂的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110446704A CN110446704A (zh) | 2019-11-12 |
CN110446704B true CN110446704B (zh) | 2022-07-05 |
Family
ID=61906763
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210807243.0A Pending CN115124470A (zh) | 2017-03-23 | 2018-03-22 | 用于制备磺酰胺结构化的激酶抑制剂的方法 |
CN201880018317.4A Active CN110446704B (zh) | 2017-03-23 | 2018-03-22 | 用于制备磺酰胺结构化的激酶抑制剂的方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210807243.0A Pending CN115124470A (zh) | 2017-03-23 | 2018-03-22 | 用于制备磺酰胺结构化的激酶抑制剂的方法 |
Country Status (8)
Country | Link |
---|---|
US (2) | US10870637B2 (zh) |
EP (2) | EP4137487A1 (zh) |
JP (2) | JP7205018B2 (zh) |
CN (2) | CN115124470A (zh) |
BR (1) | BR112019019589A2 (zh) |
ES (1) | ES2933807T3 (zh) |
FI (1) | FI3601262T3 (zh) |
WO (1) | WO2018172616A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2019334693A1 (en) * | 2018-09-06 | 2021-05-13 | Aurigene Oncology Limited | Novel hydrochloride salt forms of a sulfonamide structured kinase inhibitor |
CN114072402B (zh) * | 2019-07-26 | 2023-12-26 | 盛世泰科生物医药技术(苏州)股份有限公司 | 作为fgfr和vegfr双重抑制剂的吡啶衍生物 |
US20230119355A1 (en) * | 2020-03-05 | 2023-04-20 | Aurigene Discovery Technologies Limited | Pharmaceutical compositions of a kinase inhibitor |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103958500A (zh) * | 2011-10-10 | 2014-07-30 | 奥赖恩公司 | 蛋白激酶抑制剂 |
CN104520291A (zh) * | 2012-06-06 | 2015-04-15 | Irm责任有限公司 | 用于调节egfr活性的化合物和组合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008078100A2 (en) * | 2006-12-22 | 2008-07-03 | Astex Therapeutics Limited | Tricyclic amine derivatives as protein tyrosine kinase inhibitors |
BRPI1006128A2 (pt) * | 2009-01-12 | 2016-11-01 | Cagen Inc | derivados de sulfonamida |
WO2020135878A1 (zh) * | 2018-12-29 | 2020-07-02 | 南京明德新药研发有限公司 | 作为fgfr和vegfr双重抑制剂的咪唑并吡啶衍生物 |
KR20220020918A (ko) * | 2019-06-14 | 2022-02-21 | 메드샤인 디스커버리 아이엔씨. | Fgfr 및 vegfr 이중 억제제로서의 축합고리 화합물 |
-
2018
- 2018-03-22 US US16/495,865 patent/US10870637B2/en active Active
- 2018-03-22 WO PCT/FI2018/050214 patent/WO2018172616A1/en unknown
- 2018-03-22 CN CN202210807243.0A patent/CN115124470A/zh active Pending
- 2018-03-22 CN CN201880018317.4A patent/CN110446704B/zh active Active
- 2018-03-22 EP EP22199077.3A patent/EP4137487A1/en active Pending
- 2018-03-22 EP EP18715893.6A patent/EP3601262B1/en active Active
- 2018-03-22 JP JP2019551696A patent/JP7205018B2/ja active Active
- 2018-03-22 ES ES18715893T patent/ES2933807T3/es active Active
- 2018-03-22 FI FIEP18715893.6T patent/FI3601262T3/fi active
- 2018-03-22 BR BR112019019589A patent/BR112019019589A2/pt unknown
-
2020
- 2020-11-20 US US16/953,468 patent/US11332460B2/en active Active
-
2022
- 2022-10-17 JP JP2022166520A patent/JP7377330B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103958500A (zh) * | 2011-10-10 | 2014-07-30 | 奥赖恩公司 | 蛋白激酶抑制剂 |
CN104520291A (zh) * | 2012-06-06 | 2015-04-15 | Irm责任有限公司 | 用于调节egfr活性的化合物和组合物 |
Also Published As
Publication number | Publication date |
---|---|
US10870637B2 (en) | 2020-12-22 |
JP7205018B2 (ja) | 2023-01-17 |
US20210139462A1 (en) | 2021-05-13 |
ES2933807T3 (es) | 2023-02-14 |
EP3601262A1 (en) | 2020-02-05 |
EP4137487A1 (en) | 2023-02-22 |
EP3601262B1 (en) | 2022-11-09 |
CN115124470A (zh) | 2022-09-30 |
US11332460B2 (en) | 2022-05-17 |
JP2023011667A (ja) | 2023-01-24 |
BR112019019589A2 (pt) | 2020-04-22 |
JP7377330B2 (ja) | 2023-11-09 |
WO2018172616A1 (en) | 2018-09-27 |
FI3601262T3 (fi) | 2023-01-13 |
US20200102291A1 (en) | 2020-04-02 |
CN110446704A (zh) | 2019-11-12 |
JP2020512323A (ja) | 2020-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2554081C2 (ru) | Способ синтеза соединений диарилтиогидантоина и диарилгидантоина | |
JP7377330B2 (ja) | スルホンアミド構造のキナーゼ阻害剤の製造方法 | |
RU2388753C2 (ru) | Способ получения промежуточного продукта, участвующего в синтезе ирбесартана | |
TWI697494B (zh) | 科帕利普(copanlisib)及其二鹽酸鹽之合成 | |
JP2021509906A (ja) | Parp阻害剤の製造方法およびその中間体 | |
JP5584709B2 (ja) | 5−(2−{[6−(2,2−ジフルオロ−2−フェニルエトキシ)ヘキシル]アミノ}−1−ヒドロキシエチル)−8−ヒドロキシキノリン−2(1h)−オンの製造方法 | |
WO2010140168A1 (en) | Improved process for preparing temozolomide | |
WO2022214645A1 (en) | Processes and intermediates for the preparation of relugolix | |
AU2005273430A1 (en) | Methods for producing isoindole derivatives | |
CA2589146C (en) | Process for producing muscarine receptor antagonist and intermediate therefor | |
RU2650110C2 (ru) | Способы синтеза 2-амино-4,6-диметоксибензамида и других бензамидных соединений | |
KR101112731B1 (ko) | 3-아이오도타이로나민의 제조방법 | |
CN102351778A (zh) | 一种盐酸阿比朵尔的制备方法 | |
US20090124677A1 (en) | Method For Obtaining A Pharmaceutically Active Compound (Irbesartan) And Its Synthesis Intermediate | |
WO2014016338A1 (en) | New synthetic route for the preparation of 3-amino-piperidine compounds | |
EP3081554B1 (en) | Method for preparing silodosin and intermediate thereof | |
JP2015038053A (ja) | 4−(2−メチル−1−イミダゾリル)−2,2−フェニルブタンアミドの製造方法 | |
JP2019534313A (ja) | 光学活性ジアザスピロ[4.5]デカン誘導体の分割 | |
WO2016071382A1 (en) | Synthesis of pi3k inhibitor and salts thereof | |
JP2009500306A (ja) | キナゾリノン誘導体の合成方法 | |
WO2020020190A1 (zh) | 一种喹啉衍生物的合成方法 | |
JP6997769B2 (ja) | 2-(6-ニトロピリジン-3-イル)-9H-ジピリド[2,3-b;3’,4’-d]ピロールの製造方法 | |
JP2022114189A (ja) | 6-ハロゲノイソインドリノン誘導体の製造方法 | |
JP2022529916A (ja) | 置換された2-[2-(フェニル)エチルアミノ]アルカンアミド誘導体の製造方法 | |
ITMI20111467A1 (it) | Procedimento per la preparazione di ivabradina e di suoi intermedi di sintesi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221115 Address after: bangalore Patentee after: AURIGENE DISCOVERY TECHNOLOGIES Ltd. Address before: Espoo, Finland Patentee before: ORION Corp. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: Yin Dubanjialuoer Patentee after: Oregini Oncology Co.,Ltd. Country or region after: India Address before: Yin Dubanjialuoer Patentee before: AURIGENE DISCOVERY TECHNOLOGIES Ltd. Country or region before: India |
|
CP03 | Change of name, title or address |